Further analysis suggested that the Anti-Tumor efficacy of DTT-SP4 or DTSP was associated with an enhanced antigen-specific Th1 response and alteration of immunosuppressive Treg cells and effector CD8+ T cells in spleens and tumor tissues. Here, CD8A is linked to neoplasm.